Digital Home-Based Prehabilitation Before Surgery (dHOPE)

January 26, 2024 updated by: Vestre Viken Hospital Trust
This clinical trial compares two different prehabilitation programs, with no organized prehabilitation, prior to major colorectal cancer surgery. The prehabilitation programs include intensive and coached physical exercise and optimized nutritional intake coupled with smoking cessation, physiological support and correction of poly-pharmacy.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

Patients are randomized to either a digital home-based program, a physical hospital-based program or no-organized prehabilitation. The eligible patients are anyone scheduled for colorectal cancer surgery who are fluent in Norwegian able to consent and to understand questionnaires. The main question the study aims to answer is whether a digital home-based program is non-inferior to a hospital-based program in terms of improved physical capacity and maintenance of life-quality. In addition, blood samples will be drawn at three time points, at inclusion, after intervention (prior to surgery) and 6 weeks after surgery to analyze and search for biomarkers reflecting patients' individual surgical risk profile and response to prehabilitation. Participants randomized to intervention, will be given psychological coaching and support, individualized nutritionist counselling, coached, structured and repeated 60 minutes daily exercises for three weeks prior to surgery. The control group will receive no organized prehabilitation in the period of time between diagnose and surgery.

Study Type

Interventional

Enrollment (Estimated)

140

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Planned for major gastrointestinal cancer surgery
  • Fluent in Norwegian and able to consent and to understand questionnaires

Exclusion Criteria:

  • Inability to walk for six minutes or to rise independently from a chair
  • Inability to comprehend exercise program or to comply with written and oral instructions
  • Presence of a cardio-pulmonary condition that precludes exercise
  • Living in very remote areas making a hospital-based intervention group impossible to implement
  • Being without a permanent address
  • Admittance to a hospital facility for > 50% of the time from diagnosis to surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Hospital
Prehabilitation at the hospital, with guidance by a dedicated physiotherapist physically present.
  • Nutritional optimization: A nutritionist will perform a structured interview, comprehensive nutrition assessment, and provide personalized dietary advice. The main goal is to ensure optimal protein intake to support exercise-induced anabolism. A daily protein intake of 1.2-2.0 g/kg will meet needs as outlined in surgical nutrition guidelines.
  • Exercise: Based on current guidelines and instructed by a dedicated physiotherapist, for 1 hour per day preoperatively to increase muscle strength, aerobic capacity and physical endurance. Intensity will be based on the rate of perceived exertion using the Borg scale, a 15-graded scale ranging from very light to very hard. Resistance exercises will target upper/lower body, and abdominal muscles.
  • Psychological coaching and support: Performed as one interview during inclusion, followed by weekly phone calls by a study nurse coordinator during the preoperative intervention.
Experimental: Digital
Prehabilitation at home, with guidance from a dedicated physiotherapist through a digital platform, realtime.
  • Nutritional optimization: A nutritionist will perform a structured interview, comprehensive nutrition assessment, and provide personalized dietary advice. The main goal is to ensure optimal protein intake to support exercise-induced anabolism. A daily protein intake of 1.2-2.0 g/kg will meet needs as outlined in surgical nutrition guidelines.
  • Exercise: Based on current guidelines and instructed by a dedicated physiotherapist, for 1 hour per day preoperatively to increase muscle strength, aerobic capacity and physical endurance. Intensity will be based on the rate of perceived exertion using the Borg scale, a 15-graded scale ranging from very light to very hard. Resistance exercises will target upper/lower body, and abdominal muscles.
  • Psychological coaching and support: Performed as one interview during inclusion, followed by weekly phone calls by a study nurse coordinator during the preoperative intervention.
No Intervention: Control
Information about the general benefit of a healthy lifestyle at inclusion, thereafter no further follow-up prior to surgery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
6MWT
Time Frame: At inclusion, prior to intervention. After intervention, prior to surgery. 4-6 weeks after surgery
Distance (in meters) walked in 6 minutes
At inclusion, prior to intervention. After intervention, prior to surgery. 4-6 weeks after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
EuroQol Group Questionnaire 5D (EQ-5D)
Time Frame: At inclusion, prior to intervention. After intervention, prior to surgery. 4-6 weeks after surgery
EQ-5D is a standardized measure of health-related quality of life with 5 dimensions, each dimension represented by a value 1-5 where higher value represents worse outcome.
At inclusion, prior to intervention. After intervention, prior to surgery. 4-6 weeks after surgery
European Organisation for Research and Treatment of Cancer Core Quality of Life questionnaire
Time Frame: At inclusion, prior to intervention. After intervention, prior to surgery. 4-6 weeks after surgery
The EORTC Core Quality of Life questionnaire (EORTC QLQ-C30) is designed to measure cancer patients' physical, psychological and social functions. The questionnaire range from 0 to 100; a higher score represents a higher ("better") level of functioning, or a higher ("worse") level of symptoms.
At inclusion, prior to intervention. After intervention, prior to surgery. 4-6 weeks after surgery
Generic Short Patient Experiences Questionnaire (GS-PEQ)
Time Frame: At inclusion, prior to intervention. After intervention, prior to surgery. 4-6 weeks after surgery
GS-PEQ is a questionnaire for collecting data about user experiences across different types of services. The questionnaire has 12 questions ranging from 1-5; a higher score represents a higher ("better") experience.
At inclusion, prior to intervention. After intervention, prior to surgery. 4-6 weeks after surgery
Mortality
Time Frame: 3 months after surgery
90-day mortality
3 months after surgery
Complications
Time Frame: 3 months after surgery
Comprehensive Complication Index (CCI) reflects the gravity of the overall complication burden on the patient on a scale from 0 (no complication) to 100 (death)
3 months after surgery
Need of additional health care support
Time Frame: 4-6 weeks after surgery
Use of health care support from the municipality, nursing homes etc
4-6 weeks after surgery
Aggregated length-of-stay (aLoS)
Time Frame: 4-6 weeks after surgery
Total time in hospital (from surgery and any readmittance) within 30-days from surgery
4-6 weeks after surgery
Cost-effectiveness
Time Frame: 3 months after surgery
An estimation of the resources used on the prehabilitation program will be compared to resources saved by shorter aLoS, less use of nursing home facilities and less need of community healthcare services
3 months after surgery

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
DNA methylation
Time Frame: At inclusion, prior to intervention. After intervention, prior to surgery. 4-6 weeks after surgery
Blood samples for DNA methylation profiling will be implemented in a machine learning algorithm to search for biomarkers reliably reflecting frailty and effect of prehabilitation.
At inclusion, prior to intervention. After intervention, prior to surgery. 4-6 weeks after surgery
RNA methylation
Time Frame: At inclusion, prior to intervention. After intervention, prior to surgery. 4-6 weeks after surgery
Blood samples for RNA methylation profiling will be implemented in a machine learning algorithm to search for biomarkers reliably reflecting frailty and effect of prehabilitation.
At inclusion, prior to intervention. After intervention, prior to surgery. 4-6 weeks after surgery
Metabolome
Time Frame: At inclusion, prior to intervention. After intervention, prior to surgery. 4-6 weeks after surgery
Blood samples for metabolome profiling will be implemented in a machine learning algorithm to search for biomarkers reliably reflecting frailty and effect of prehabilitation.
At inclusion, prior to intervention. After intervention, prior to surgery. 4-6 weeks after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Rune Ougland, MD PhD, Vestre Viken, Bærum Hospital, Norway

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

February 1, 2024

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

December 31, 2030

Study Registration Dates

First Submitted

November 17, 2023

First Submitted That Met QC Criteria

January 26, 2024

First Posted (Actual)

January 30, 2024

Study Record Updates

Last Update Posted (Actual)

January 30, 2024

Last Update Submitted That Met QC Criteria

January 26, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 23/08551

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Protocol and SAP will be published together with results from the pilot study

IPD Sharing Time Frame

By end of 2024

IPD Sharing Access Criteria

Upon request

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe